Lyra Therapeutics Inc (NASDAQ: LYRA) is -2.76% lower on its value in year-to-date trading and has touched a low of $0.16 and a high of $6.79 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LYRA stock was last observed hovering at around $0.22 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $0.20, the stock is 3.29% and -5.40% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.28 million and changing -7.21% at the moment leaves the stock -80.07% off its SMA200. LYRA registered -96.26% loss for a year compared to 6-month loss of -31.43%. The firm has a 50-day simple moving average (SMA 50) of $0.2132 and a 200-day simple moving average (SMA200) of $1.03734.
The stock witnessed a -6.61% gain in the last 1 month and extending the period to 3 months gives it a -8.19%, and is -2.76% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.22% over the week and 11.60% over the month.
Lyra Therapeutics Inc (LYRA) has around 88 employees, a market worth around $13.14M and $1.47M in sales. Profit margin for the company is -6635.76%. Distance from 52-week low is 23.51% and -97.04% from its 52-week high. The company has generated returns on investments over the last 12 months (-187.93%).
The EPS is expected to shrink by -6.83% this year
83.0 institutions hold shares in Lyra Therapeutics Inc (LYRA), with institutional investors hold 60.11% of the company’s shares. The shares outstanding are 65.46M, and float is at 54.79M with Short Float at 3.35%. Institutions hold 59.75% of the Float.
The top institutional shareholder in the company is PERCEPTIVE ADVISORS LLC with over 12.76 million shares valued at $3.53 million. The investor’s holdings represent 19.9302 of the LYRA Shares outstanding. As of 2024-06-30, the second largest holder is CITADEL ADVISORS LLC with 4.77 million shares valued at $1.32 million to account for 7.4562 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 2.83 million shares representing 4.4211 and valued at over $0.78 million, while SAMSARA BIOCAPITAL, LLC holds 4.3434 of the shares totaling 2.78 million with a market value of $0.77 million.
